Aquinox Pharmaceuticals Total Assets 2013-2018 | AQXP

Aquinox Pharmaceuticals total assets from 2013 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Aquinox Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $78
2017 $110
2016 $154
2015 $113
2014 $41
2013 $16
2012 $2
Aquinox Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q4 2018 $78
Q3 2018 $88
Q2 2018 $104
Q1 2018 $96
Q4 2017 $110
Q3 2017 $122
Q2 2017 $133
Q1 2017 $143
Q4 2016 $154
Q3 2016 $164
Q2 2016 $101
Q1 2016 $108
Q4 2015 $113
Q3 2015 $118
Q2 2015 $30
Q1 2015 $35
Q4 2014 $41
Q3 2014 $49
Q2 2014 $53
Q1 2014 $56
Q4 2013 $16
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $2
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.063B $0.025B
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $48.675B 8.76
Teva Pharmaceutical Industries (TEVA) Israel $16.168B 5.58
Mylan (MYL) United Kingdom $14.612B 6.18
Bausch Health Cos (BHC) Canada $8.444B 6.01
Dr Reddy's Laboratories (RDY) India $6.645B 26.50
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.805B 2.93
Supernus Pharmaceuticals (SUPN) United States $1.794B 16.64
Homology Medicines (FIXX) United States $0.987B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.956B 88.87
CymaBay Therapeutics (CBAY) United States $0.715B 0.00
Voyager Therapeutics (VYGR) United States $0.624B 0.00
Assembly Biosciences (ASMB) United States $0.452B 0.00
Akorn (AKRX) United States $0.431B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.363B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.200B 0.00
Sol-Gel Technologies (SLGL) Israel $0.128B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.121B 0.00
Acasti Pharma (ACST) Canada $0.082B 0.00
Agile Therapeutics (AGRX) United States $0.066B 0.00
Teligent (TLGT) United States $0.058B 0.00
Evoke Pharma (EVOK) United States $0.025B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.013B 0.00